Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms
Top Cited Papers
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 158 (5), 1250-1261.e2
- https://doi.org/10.1053/j.gastro.2019.12.014
Abstract
No abstract availableFunding Information
- My Total Health
- Ironwood Pharmaceuticals
- The Marc and Sheri Rapaport
- American College of Gastroenterology
- National Institutes of Health
- National Center for Advancing Translational Science (UL1TR001881)
This publication has 48 references indexed in Scilit:
- Patient-Reported Outcomes in Gastroenterology: Clinical and Research ApplicationsJournal of Neurogastroenterology and Motility, 2013
- Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in JapanThe Esophagus, 2011
- A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in ChinaBMC Gastroenterology, 2010
- Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studiesAlimentary Pharmacology & Therapeutics, 2010
- Epidemiology and clinical characteristics of GERD in the Japanese populationThe Esophagus, 2009
- Prevalence and Risk Factors for Overlaps between Gastroesophageal Reflux Disease, Dyspepsia, and Irritable Bowel Syndrome: A Population-Based StudyDigestion, 2009
- Gastroesophageal Reflux Disease (GERD)Journal of Clinical Gastroenterology, 2009
- Prevalence and Socioeconomic Impact of Upper Gastrointestinal Disorders in the United States: Results of the US Upper Gastrointestinal StudyClinical Gastroenterology and Hepatology, 2005
- Gastroesophageal reflux among different racial groups in the United StatesGastroenterology, 2004
- U. S. Householder survey of functional gastrointestinal disordersDigestive Diseases and Sciences, 1993